Author Archives: Antigone Barton

DRC Ebola outbreak not a PHEIC, but challenges, risks remain daunting, requiring investments

By on .

A World Health Organization-convened committee examining the Ebola outbreak in the Democratic Republic of Congo concluded today that the current conditions of the outbreak do not constitute an international health emergency, but do continue to pose significant challenges that could warrant revisiting the question. WHO Director General Tedros Ghebreyesus called for the committee to weigh […]

More than half of children living with HIV still without treatment in high burden, PEPFAR-supported southern African countries

By on .

While a growing number of countries have adopted World Health Organization guidelines recommending antiretroviral treatment for all children with HIV, more than half of children living with the virus in the highest burden countries in sub-Saharan Africa remain untreated, according to a report released today. The report notes that pediatric HIV treatment coverage nearly doubled between […]

WHO Essential Diagnostics List provides guide to tools needed for global health responses

By on .

Tools to diagnose and monitor HIV, hepatitis B and C, and tuberculosis, as well as resistance to first-line TB treatment are among the tests included in World Health Organization’s first List of Essential In Vitro Diagnostics, released Tuesday. The list, divided into tests needed in primary health care settings that can include community health centers […]

Report: Develop surveillance, diagnosis, treatments and vaccines to prepare for catastrophic pandemic potential pathogens

By on .

The next disease with the potential to sweep the planet with devastation on a scale of that caused by the influenza pandemic of 1918 is likely also to be caused by a virus. As happened then, the virus will likely be spread by the unavoidable act of breathing, and transmitted by people who don’t feel […]

What we’re reading: Drug prices and global free-loading? Or pharmaceutical free-loading?

By on .

On Friday, as the World Health Organization, related agencies, and international nonprofits geared up for the challenges confronting swift responses to the latest Ebola outbreak in the Democratic Republic of Congo, the Trump administration released a plan to bring down the price of medicines for diseases here in the United States. Among its analyses of […]

White House rescission proposal, House resolution highlight disconnect between federal priorities, global realities

By on .

On Tuesday, as the World Health Organization announced that Ebola had broken out in the Democratic Republic of Congo for the second time in a year, and the ninth time since the discovery of the disease there in the late 1970s, the White House released one more proposal to to cut funding for global and […]

Democratic Republic of Congo declares Ebola outbreak after two confirmed cases

By on .

Laboratory confirmation of two cases of Ebola in Bikoro, a lakeside market town in the northwestern region of the Democratic Republic of Congo has prompted government health officials there to declare an outbreak of the virus, the World Health Organization announced today. WHO, Médecins Sans Frontières, and provincial health officials have sent teams to the […]

What we’re reading: HIV prevention options and a ticking clock, “protecting life” while defunding ID services, and overcoming a challenge to opioid ID prevention

By on .

Why a promising new approach to HIV prevention could lose funding – From explaining the ways in which HIV can be stopped from infecting a new person, to explaining why research and development of prevention options could narrow in the next two years, health and science writer Heather Boerner tells how focus in the search […]

Analysis: Global health research and development spending comes home, in disease solutions and dollars

By on .

With budget proposals titled “America First: A Budget Blueprint to Make America Great Again“ for fiscal year 2018, and “An American Budget” for 2019, the premise of White House budget plans that would slash funding for global health research and development to levels not seen since the start of this century seemed predicated on the […]